Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Congress on the Brink of Disrupting the PBM Market

Congress on the Brink of Disrupting the PBM Market

Jan 27, 2025 | Commentary

During much of 2024, the prevailing view in Washington was that some policies related to pharmacy benefit managers (PBMs) would be included in the end-of-year continuing resolution.

Economics of “Delinking” Are Still Not Good

Economics of “Delinking” Are Still Not Good

Dec 13, 2024 | Commentary

Delinking would lead to higher costs for patients and taxpayers and put more money in the pockets of brand drug manufacturers.

The Economics of “Delinking” PBM Compensation

The Economics of “Delinking” PBM Compensation

Nov 2, 2023 | Commentary

Pharmacy benefit managers (PBMs) are a popular Congressional target of late.

Unintended Consequences of Limiting PBMs

Unintended Consequences of Limiting PBMs

Sep 26, 2023 | Commentary

As Congress stumbles toward a government shutdown, health policy legislation continues to simmer in the background.

Taking Stock of the Humira Biosimilars Market

Taking Stock of the Humira Biosimilars Market

Jun 26, 2023 | Commentary

In January, the 21-year monopoly for AbbVie’s blockbuster drug Humira (adalimumab) came to an end with the launch of Amjevita, Amgen’s biosimilar adalimumab.

  • Analysis (49)
  • Books (3)
  • Commentary (15)
  • Events (21)
  • Interviews (59)
  • News (55)
  • Op-Eds (96)
  • Press Releases (4)
  • Testimony (21)
  • a conversation on tax reform
    A Conversation with House Ways and Means Committee Chairman Jason Smith on Tax ReformMarch 5, 2025
  • US Biosimilars Market
    New MGA Paper Identifies Barriers to US Biosimilar Success in the Second DecadeMarch 5, 2025
  • Congress on the Brink of Disrupting the PBM Market
    Congress on the Brink of Disrupting the PBM MarketJanuary 27, 2025
  • Raising the Salt Cap Would Increase Tax Complexity
    Raising the Salt Cap Would Increase Tax ComplexityJanuary 13, 2025
  • Economics of “Delinking” Are Still Not Good
    Economics of “Delinking” Are Still Not GoodDecember 13, 2024
  • Child Tax Credit Tradeoffs
    The Child Tax Credit: Tradeoffs and PreferencesOctober 30, 2024
  • Oregon’s Measure 118 Turnover Tax
    Oregon’s Measure 118: The Turnover Tax Is the WorstOctober 29, 2024
  • Dueling Child Tax Credit Proposals
    Dueling Child Tax Credit Proposals: Harris vs. VanceOctober 21, 2024
  • Deduction for Auto Loan Interest
    Trump Proposes Bringing Back the Deduction for Auto Loan InterestOctober 16, 2024
  • Overtime Income Tax Break
    Overtime Income Tax Break: Not Illogical, Just Costly and ComplicatedOctober 7, 2024
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact